Inari Medical, a company that develops devices for venous and other diseases, has agreed to buy LimFlow, a company that offers a minimally-invasive solution for patients with severe peripheral artery disease who face leg amputation. The deal is worth up to $415 million and is expected to close by the end of 2023. LimFlow’s technology,…